Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992;34(4):265-71.
doi: 10.1007/BF01741795.

Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours

Affiliations

Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours

K A Quinn et al. Cancer Immunol Immunother. 1992.

Erratum in

  • Cancer Immunol Immunother 1992;35(3):223

Abstract

Neutralisation studies with monoclonal antibodies (mAbs) specific for early pregnancy factor (EPF) have shown it to be essential for the continuation of pregnancy in mice and the growth of some tumour cells in vitro. These studies report that the mAbs are also able to limit the growth of two murine tumour lines transplanted s.c. The development of MCA-2 tumours in CBA mice was unaffected by the injection of 1 mg anti-EPF IgM at the time of tumour cell inoculation. However, four doses of 500 micrograms anti-EPF, injected one dose per day for 4 days after tumour cell inoculation, significantly retarded tumour development such that no tumours were palpable on day 13. A similar dose regimen of control IgM had no effect on tumour size. Dose/response studies revealed that lower doses of anti-EPF administered after tumour cell inoculation were effective in retarding the growth of the MCA-2 tumours. The effects of anti-EPF mAb administration on the growth rate of palpable B16 tumours established s.c. in C57BL/6 mice was also determined. Tumours injected with 6 mg anti-EPF 5/341 or anti-EPF 5/333 mAbs showed significant decrease in the uptake of [3H]thymidine into tumour tissue, measured 16 h after injection. Furthermore, titration of sera for active EPF showed that a significant reduction in the EPF titre was associated with a significant inhibition of tumour DNA synthesis. Thus it appears that neutralisation of EPF retards tumour growth both in vitro and in vivo. In vitro the effects must be due to anti-EPF mAb interfering with a direct mechanism that contributes to the maintenance of cells in the active growing phase. However, in vivo host immunological mechanism that are modified to allow tumour survival may also be affected. The presence of EPF-induced suppressor factor circulating in the serum of tumour-bearing mice has been confirmed and the contribution of such factors to tumour progression must now be investigated.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Athanasas-Platsis S, Quinn KA, Wong TY, Rolfe BE, Cavanagh AC, Morton H. Passive immunization of pregnant mice against early pregnancy factor causes loss of embryonic viability. J Reprod Fertil. 1989;87:495. - PubMed
    1. Athanasas-Platsis S, Morton H, Dunglison GF, Kaye PL. Antibodies to early pregnancy factor retard embryonic development in vivo in mice. J Reprod Fertil. 1991;92:443. - PubMed
    1. Bach JF, Dormont J, Dardenne M, Balner H. In vitro rosette inhibition by anti-human ALS. Transplantation. 1969;8:265. - PubMed
    1. Burton K. Studies of conditions and mechanisms of diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956;62:315. - PMC - PubMed
    1. Cavanagh AC. Production in vitro of mouse pregnancy factor and purification to homogeneity. J Reprod Fertil. 1984;71:581. - PubMed

Publication types

LinkOut - more resources